Matches in Wikidata for { <http://www.wikidata.org/entity/Q96431195> ?p ?o ?g. }
- Q96431195 description "2020 nî lūn-bûn" @default.
- Q96431195 description "2020年の論文" @default.
- Q96431195 description "2020年学术文章" @default.
- Q96431195 description "2020年学术文章" @default.
- Q96431195 description "2020年学术文章" @default.
- Q96431195 description "2020年学术文章" @default.
- Q96431195 description "2020年学术文章" @default.
- Q96431195 description "2020年学术文章" @default.
- Q96431195 description "2020年學術文章" @default.
- Q96431195 description "2020年學術文章" @default.
- Q96431195 description "2020年學術文章" @default.
- Q96431195 description "2020年學術文章" @default.
- Q96431195 description "2020年學術文章" @default.
- Q96431195 description "2020년 논문" @default.
- Q96431195 description "article científic" @default.
- Q96431195 description "article scientific" @default.
- Q96431195 description "article scientifique" @default.
- Q96431195 description "articol științific" @default.
- Q96431195 description "articolo scientifico" @default.
- Q96431195 description "artigo científico" @default.
- Q96431195 description "artigo científico" @default.
- Q96431195 description "artigo científico" @default.
- Q96431195 description "artikel ilmiah" @default.
- Q96431195 description "artikull shkencor" @default.
- Q96431195 description "artikulong pang-agham" @default.
- Q96431195 description "artykuł naukowy" @default.
- Q96431195 description "artículo científico publicado en 2020" @default.
- Q96431195 description "artículu científicu" @default.
- Q96431195 description "bilimsel makale" @default.
- Q96431195 description "bài báo khoa học" @default.
- Q96431195 description "naučni članak" @default.
- Q96431195 description "scienca artikolo" @default.
- Q96431195 description "scientific article published on 15 June 2020" @default.
- Q96431195 description "scientific article published on 15 June 2020" @default.
- Q96431195 description "scientific article published on 15 June 2020" @default.
- Q96431195 description "teaduslik artikkel" @default.
- Q96431195 description "tieteellinen artikkeli" @default.
- Q96431195 description "tudományos cikk" @default.
- Q96431195 description "vedecký článok" @default.
- Q96431195 description "vetenskaplig artikel" @default.
- Q96431195 description "videnskabelig artikel udgivet 15. juni 2020" @default.
- Q96431195 description "vitenskapelig artikkel" @default.
- Q96431195 description "vitskapeleg artikkel" @default.
- Q96431195 description "vědecký článek" @default.
- Q96431195 description "wetenschappelijk artikel" @default.
- Q96431195 description "wissenschaftlicher Artikel" @default.
- Q96431195 description "επιστημονικό άρθρο" @default.
- Q96431195 description "мақолаи илмӣ" @default.
- Q96431195 description "наукова стаття, опублікована в червні 2020" @default.
- Q96431195 description "научна статия" @default.
- Q96431195 description "научная статья" @default.
- Q96431195 description "научни чланак" @default.
- Q96431195 description "научни чланак" @default.
- Q96431195 description "מאמר מדעי" @default.
- Q96431195 description "مقالة علمية نشرت في 15 يونيو 2020" @default.
- Q96431195 description "১৫ জুন ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q96431195 description "บทความทางวิทยาศาสตร์" @default.
- Q96431195 description "სამეცნიერო სტატია" @default.
- Q96431195 name "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (" @default.
- Q96431195 name "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (" @default.
- Q96431195 type Item @default.
- Q96431195 label "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (" @default.
- Q96431195 label "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (" @default.
- Q96431195 prefLabel "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (" @default.
- Q96431195 prefLabel "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (" @default.
- Q96431195 P1433 Q96431195-AE13E0D0-B910-4DB3-A7FD-6F339106DC4A @default.
- Q96431195 P1476 Q96431195-DF01E146-5AB1-43F6-9A90-9C0B59681289 @default.
- Q96431195 P2093 Q96431195-076BDD39-914B-48CA-A01D-CB3674B493B9 @default.
- Q96431195 P2093 Q96431195-1FAE40C4-A7FF-48DA-9627-0C297C8F3230 @default.
- Q96431195 P2093 Q96431195-22323F35-E023-4F75-9865-A23F9F7EB112 @default.
- Q96431195 P2093 Q96431195-274F4E84-8550-426F-9FE8-A915506932DC @default.
- Q96431195 P2093 Q96431195-2F78F696-CCFE-4683-ACCD-0DE3C9D21FA2 @default.
- Q96431195 P2093 Q96431195-3AC0A99B-1D98-4A6E-BFA0-2152272F1143 @default.
- Q96431195 P2093 Q96431195-4C7B2AF9-E793-4F20-8690-0FB1A76D0DF9 @default.
- Q96431195 P2093 Q96431195-5144A138-4F3B-478D-885F-6C8FAB4208D8 @default.
- Q96431195 P2093 Q96431195-8CCD7ED2-30CB-4C58-9602-B29166A22460 @default.
- Q96431195 P2093 Q96431195-8FB7D505-FF24-46A6-908E-68E9381C4C99 @default.
- Q96431195 P2093 Q96431195-9D7766E7-FD19-4FAB-B903-23CAB01964EC @default.
- Q96431195 P2093 Q96431195-A0267C9E-C8A2-430F-82ED-A880E9843851 @default.
- Q96431195 P2093 Q96431195-A4C93F0E-B3F4-4150-93A3-E690FBA55497 @default.
- Q96431195 P2093 Q96431195-A93B1403-B205-4856-B079-A007281CF772 @default.
- Q96431195 P2093 Q96431195-AB1C2060-1EE2-4710-BAD6-F11C3BDA4813 @default.
- Q96431195 P2093 Q96431195-BB89D2C6-AAB8-4770-B888-0197C43D9E90 @default.
- Q96431195 P2093 Q96431195-FB6A3383-AD04-48FF-AE1C-83B383F34C22 @default.
- Q96431195 P2093 Q96431195-FF6E0763-506F-4301-B4B8-D36C490423DF @default.
- Q96431195 P31 Q96431195-8EA2F893-7DB1-45DF-8A16-889A3ED8F314 @default.
- Q96431195 P356 Q96431195-AB6DCA54-4CDD-4FDB-8ECA-10E96C99A2EC @default.
- Q96431195 P50 Q96431195-66266B55-D89D-4EC2-B842-E06BDF9B17E4 @default.
- Q96431195 P577 Q96431195-D7B459D8-CB9C-41BC-9003-676677C6C551 @default.
- Q96431195 P698 Q96431195-EE84004E-CD92-48EC-8FB3-BBB94B301DAE @default.
- Q96431195 P921 Q96431195-0520FB49-59B6-4763-9ED0-6ECCE8451447 @default.
- Q96431195 P921 Q96431195-06DF2CEB-A441-428C-AB70-C56840ABB640 @default.
- Q96431195 P921 Q96431195-93BFE54D-7595-4E43-B0B2-D3D0A19FFD5B @default.
- Q96431195 P356 IJGC-2020-001519 @default.
- Q96431195 P698 32546554 @default.
- Q96431195 P1433 Q15749181 @default.
- Q96431195 P1476 "A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)" @default.
- Q96431195 P2093 "Anjana Anand" @default.
- Q96431195 P2093 "Anne Floquet" @default.
- Q96431195 P2093 "Annekke Westermann" @default.